Strong Buy

What Makes This Biotech A “Strong Buy”? An Underappreciated – And Potentially Transformative – Late-Stage Pipeline

by Alex Clarke
May 28, 2021May 28, 2021

The biotech featured in today’s article “selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology, and provide… Read More »What Makes This Biotech A “Strong Buy”? An Underappreciated – And Potentially Transformative – Late-Stage Pipeline

3 “Strong Buy” Pharma Stocks With Significant Upside Potential – And Catalysts Around The Corner

by Alex Clarke
July 28, 2020April 17, 2021

Regarding investor behavior amid the current market volatility, the author of today’s article observes that “A select group remains ready to take on some risk,… Read More »3 “Strong Buy” Pharma Stocks With Significant Upside Potential – And Catalysts Around The Corner